-
Published 1/2/2026
Keegan J, Sorbello S, Mori J, Muratani S, Leshchiner I, Heaphy CM, Flynn RL. Functional inactivation of the telomerase chaperone TCAB1 primes cells for the activation of ALT in osteosarcoma. bioRxiv. 2026 Jan 02. PMID: 41509329.
-
Published 12/1/2025
Belakhoua S, Lopez G, Dubey S, Rai S, Chen L, Chen S, Pallavajjala A, Yuan M, Pekmezci M, Stojanova M, Heaphy CM, Eberhart CG, Rodriguez FJ. RECQL4 alterations in gliomas and nerve sheath tumors: Expression patterns and therapeutic implications. J Neuropathol Exp Neurol. 2025 Dec 01; 84(12):1191-1201. PMID: 41317405.
-
Published 8/8/2025
Wood-Trageser MA, Nichols CT, Hutchings DA, Bell D, Wald AI, Smith K, Hong SM, Luchini C, Brosens LAA, Verschuur AVD, Bevere M, Lawlor RT, Scarpa A, Keating S, Tucker J, O'Sullivan RJ, Liu TC, McGrath K, Fasanella K, Brand RE, Lennon AM, Das R, Singh H, Slivka A, Mahmood S, Hosmer AE, Khalid A, Romutis SL, Zureikat AH, Zeh HJ, Hogg ME, Lee KK, Paniccia A, Nunns G, Ongchin M, Park WG, Polanco PM, He J, Simeone DM, Ferrone CR, Hsu D, Zhang J, Gorantla V, Rhee J, Hruban RH, Singhi AH, Singhi SA, Wang CK, Shaker N, Bubar R, Grupillo M, Lai YT, Nikiforova MN, Heaphy CM, Waters KM, Singhi AD. Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis. Mod Pathol. 2025 Oct; 38(10):100863. PMID: 40784487.
-
Published 7/24/2025
Solivio C, Yuan G, Rizzo AJ, Graham MK, Shenker L, Vista W, Gil A, Singh H, Alexander E, Gonzalez-Aguirre A, Latzman J, Petre EN, Yarmohammadi H, Erinjeri JP, Covey A, Chan E, Russell J, Bodei L, Raj N, Reidy-Lagunes D, Heaphy CM, Ziv E. Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization. Neuroendocrinology. 2025; 115(9):730-740. PMID: 40706576.
-
Published 7/19/2025
Arbesfeld-Qiu JM, Cho JW, Nguyen PTT, Lester NA, Su J, Guo JA, Hoffman H, Shiau C, Caldwell N, Muratani S, Galvan M, Proctor JE, Ely Z, Wang S, Ganci M, Dries R, Hong T, Wo J, Boland G, Fernandez-Del Castillo C, Ferrone C, Heaphy CM, Zhang ML, Mino-Kenudson M, Hemberg M, Hwang WL. Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors. bioRxiv. 2025 Jul 19. PMID: 40791359.